Plant Summary
Plant Information
TCMBank_ID: | TCMBANKHE006088 |
ID: | TCMBANKHE006088 |
植物拉丁名: |
|
功能与主治: | See Patrinia villosa ./See Patrinia villosa. |
药用植物名: | 黄花败酱 |
药用部位: | whole herb |
TCM_ID_id: | 1134 |
植物对应的化合物
| 化合物ID | 化合物名 | 别名 | 分子式 | 分子质量 | Smiles |
|---|
| TCMBANKIN000077 | sulfur dioxide | Sulfurous acid anhydride; Sulfur superoxide; FEMA 3039; FEMA No. 3039; Sulfur dioxide [NF]; Sulfur dioxide (SO2); 8014-94-6; CHEMBL1235997; CTK2H7729; Sulfur dioxide (NF); Caswell No. 813; [SO2]; D05961; Sulfur dioxide,liquid; Schwefeldioxyd; Schwefeldioxid; Sulfur dioxide [UN1079] [Poison gas]; Fermenicide liquid; SO2; 115004-27-8; sulphur dioxide; Sulfurous oxide; CHEBI:18422; Sulfur dioxide (SO2) 10% by volume or more SO2; AKOS015904447; SC-81833; 12396-99-5; Sulfurous anhydride; Sulfur dioxide, >=99.9%; R-764; Oxosulfane oxide #; I14-17276; HSDB 228; Fermenticide liquid; Surfur dioxide (anhydrous); sulfer dioxide; RAHZWNYVWXNFOC-UHFFFAOYSA-; Sulfur dioxide, puriss., >=99.9%; Oxosulfane oxide; EPA Pesticide Chemical Code 077601; E220; ACMC-1BHHQ; Sulfur oxide (SO2); DTXSID6029672; LS-3224; Siarki dwutlenek; Sulfur dioxide [UN1079] [Poison gas]; Fermenicide powder; Schwefeldioxyd [German]; 7446/9/5; C09306; CCRIS 9001; Sulfur(IV) oxide; dioxidosulfur; Sulfur dioxide, >=99.98%; 1239882-82-6; AC1L1ARN; TR-024070; UN1079; Siarki dwutlenek [Polish]; InChI=1/O2S/c1-3-2; SULFUR-DIOXIDE; Dioxide, Sulfur; Schwefel(IV)-oxid; UN 1079; 0UZA3422Q4; RAHZWNYVWXNFOC-UHFFFAOYSA-N; EC 231-195-2; 83008-56-4; EINECS 231-195-2; Sulfurdioxide; 89125-89-3; UNII-0UZA3422Q4; Anhydride, Sulfurous | SO2 | 64.07 g/mol | O=S=O |
| TCMBANKIN000971 | guaia-6-en-4,10-diol | ||||
| TCMBANKIN001447 | Isopatriscabrol | C10H16O4 | 200.23 g/mol | CC1C2CC(C(C2COC1=O)(C)O)O | |
| TCMBANKIN001950 | sapindoside a | NSC106553; NCI60_000155; STL454351; A-L-arabinopyranosyl]oxy]-23-hydroxyolean-12-en-28-oic acid; A-L-mannopyranosyl)-; A)-3-[[2-O-(6-Deoxy-; NSC-106553; AC1Q5V6H; Olean-12-en-28-oic acid, (3.beta.,4.alpha.)-; Sapindoside A; CHEMBL1980760; 10-[4,5-dihydroxy-3-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxyoxan-2-yl]oxy-9-(hydroxymethyl)-2,2,6a,6b,9,12a-hexamethyl-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylic acid; .alpha.-Hederin; 27013-91-8; 3-{[2-o-(6-deoxyhexopyranosyl)pentopyranosyl]oxy}-23-hydroxyolean-12-en-28-oic acid; AC1L6I0J; A,4 | C41H66O12 | 751 g/mol | CC1C(C(C(C(O1)OC2C(C(COC2OC3CCC4(C(C3(C)CO)CCC5(C4CC=C6C5(CCC7(C6CC(CC7)(C)C)C(=O)O)C)C)C)O)O)O)O)O |
| TCMBANKIN002275 | patrinoside M | ||||
| TCMBANKIN003162 | oleanolic acid 3-O-β-D-glucopyranosyl(1→3)-α-L-rhamnopyranosyl(1→2)-α-L-arabinopyranoside | ||||
| TCMBANKIN003343 | Scabroside L | C27H36O6 | CC(CO)C1=C2C3CC(C(=CC(C3(CCC2(CC1)CO)C)O)COC(=O)C4=CC=CC=C4)O | ||
| TCMBANKIN005334 | 3-O-β-D-xylopyranosyl(1→3)-α-L-rhamnopyranosyl(1→2)-α-L-arabinopyranosyloleanolicacid 28-O-β-D-glucopyranosyl ester | ||||
| TCMBANKIN005377 | Patriscabrol | C10H16O4 | 200.23 g/mol | CC1C2CC(C(C2COC1=O)(C)O)O | |
| TCMBANKIN005830 | 3-O-β-D-glucopyranosyl-(1→3)-α-L-rhamanopyranosyl-(l→2)-β-D-araopyranosyl oleanolic acid | ||||
| TCMBANKIN006110 | hederagenin-3-o-α-l-arabinopyranosyl-28-o-β-d-glucopyranosyl(1→6)-β-d-glucopyranoside | C47H76O18 | |||
| TCMBANKIN007086 | patrinoside B1 | ||||
| TCMBANKIN007089 | patrinoside J | ||||
| TCMBANKIN007193 | 3-O-β-D-xylcopyranosyl-(1→3)-α-L-rhamano pyranosyl-(1→2)-α-L-araopyranosyl oleanolic acid-28-O-β-D-glucopyranoside | ||||
| TCMBANKIN007283 | 3-methyl-7-hydroxy-3,4-dihydrocoumarinesculetin | ||||
| TCMBANKIN007806 | Jatamanin A | C10H14O4 | 198.22 g/mol | CC1(C(CC2C1C(=O)OCC2=C)O)O | |
| TCMBANKIN008286 | 3-hydroxy-olean-11-oxo-12-en-28-oic acid | ||||
| TCMBANKIN008342 | scabioside e | CC1C(C(C(C(O1)OC2COC(C(C2O)O)OC(=O)C34CCC(CC3C5=CCC6C7(CCC(C(C7CCC6(C5(CC4)C)C)(C)C)OC8C(C(C(CO8)OC9C(C(C(C(O9)CO)O)O)O)O)O)C)(C)C)O)O)O | |||
| TCMBANKIN009065 | 3-o-β-d-glucopyranosyl-(1→3)-α-l-rhamnopy-ranosyl-(1→2)-β-d-xylopyranosyl oleanolicacid | C47H76O16 | |||
| TCMBANKIN011098 | sieboldianaside A | ||||
| TCMBANKIN011700 | patrinoside E | C30H40O13 | CC(C)CC(=O)OC1C2C(CC(C2CO)OC(=O)C=CC3=CC=C(C=C3)O)C(=CO1)COC4C(C(C(C(O4)CO)O)O)O | ||
| TCMBANKIN012014 | scabroside | AC1O3DZ4; [(2S,3R,4R,5S,6S)-4-acetyloxy-2-(acetyloxymethyl)-6-[[(3S,4R,4aS)-4-ethenyl-8-oxo-4,4a,5,6-tetrahydro-3H-pyrano[3,4-c]pyran-3-yl]oxy]-5-benzoyloxyoxan-3-yl] 2-hydroxy-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxybenzoate | C15H22O10 | 362.33 g/mol | CC1=COC(C2C1(C(C3C2O3)O)O)OC4C(C(C(C(O4)CO)O)O)O |
| TCMBANKIN012511 | 3-O-rhamnopanosyl-(1→2)-xylopyanosyl-oleanolic acid-28-O-glucopyanosyl ester | ||||
| TCMBANKIN013311 | Scabroside J | C21H30O4 | CC(CO)C1=C2C3=CC=C(CC(C3(CCC2(CC1)CO)C)OC)C=O | ||
| TCMBANKIN015007 | patrinoside L | ||||
| TCMBANKIN015325 | scabioside f | CC1C(C(C(C(O1)OC2COC(C(C2O)O)OC(=O)C34CCC(CC3C5=CCC6C7(CCC(C(C7CCC6(C5(CC4)C)C)(C)C)OC8C(C(C(CO8)OC9C(C(C(C(O9)CO)O)O)O)O)O)C)(C)C)O)OC1C(C(C(CO1)O)O)O)O | |||
| TCMBANKIN015384 | scabioside g | CC1C(C(C(C(O1)OC2COC(C(C2O)O)OC(=O)C34CCC(CC3C5=CCC6C7(CCC(C(C7CCC6(C5(CC4)C)C)(C)C)OC8C(C(C(CO8)OC9C(C(C(C(O9)CO)O)O)O)O)O)C)(C)C)O)OC1C(C(C(CO1)OC1C(C(C(C(O1)CO)O)O)O)O)O)O | |||
| TCMBANKIN015445 | patrinoside A1 | ||||
| TCMBANKIN016086 | 3-o-β-d-glucopyranosyl(1→3)-α-l-arabino-pyranosyl oleanolicacid | C92H142O46 | CC1C(C(C(C(O1)OCC2C(C(C(C(O2)OC3C(C(OC(C3O)OC4COC(C(C4O)O)OC5C(C(OC(C5O)OC6C(C(COC6OC7CCC8(C(C7(C)C)CCC9(C8CC=C1C9(CCC2(C1CC(CC2)(C)C)C(=O)OC1C(C(C(C(O1)COC1C(C(C(C(O1)CO)OC1C(C(C(C(O1)C)O)O)O)O)O)O)O)O)C)C)C)O)O)C)O)CO)O)O)OC(=O)C=CC1=CC(=C(C=C1)OC)O)O)O)O)O | ||
| TCMBANKIN016330 | 29-hydroxyDehydropachymic acid | C33H50O6 | 542.7 g/mol | CC(C)C(=C)CCC(C1C(CC2(C1(CC=C3C2=CCC4C3(CCC(C4(C)CO)OC(=O)C)C)C)C)O)C(=O)O | |
| TCMBANKIN016421 | ergost-6,22-dien-3β,5α,8α-triol | ||||
| TCMBANKIN017757 | Oleanolic acid-28-O-beta-D-glucopyranoside | oleanolicacid-28-o-β-d-glucopyranoside; oleanolic acid-28-o-beta-d-glucopyranoside | C36H58O8 | 618.8 g/mol | CC1(CCC2(CCC3(C(=CCC4C3(CCC5C4(CCC(C5(C)C)O)C)C)C2C1)C)C(=O)OC6C(C(C(C(O6)CO)O)O)O)C |
| TCMBANKIN018933 | Patriscabroside I | C16H26O9 | 362.37 g/mol | CC1C2CC(C(C2COC1=O)(C)O)OC3C(C(C(C(O3)CO)O)O)O | |
| TCMBANKIN019183 | daucostarine | ||||
| TCMBANKIN019902 | 3, 4-dihydroxybenzoicacid4-O-(4′-O-methyl)-β-D-glucopyranoside | ||||
| TCMBANKIN020240 | oleanolic acid 3-O-α-L-rhamnopyranosyl-(1→2)-α-L-arabinopyranoside | ||||
| TCMBANKIN020357 | 3-o-[α-l-rhamnopyranosyl(1→2)]-[β-d-gluco-pyranosyl(1→3)]-α-l-arabinopyranosyloleano-licacid | C47H76O16 | |||
| TCMBANKIN021263 | oleanolic acid 28-O-β-D-glucopyranosyl-(1→6)-β-D-glucopyranosyl ester | ||||
| TCMBANKIN023813 | patrinoside H | ||||
| TCMBANKIN024317 | oleanolic acid-3-O-β-D-xylopy-ranoside | oleanolic acid 3-O-β-D-xylopyranoside | |||
| TCMBANKIN025135 | patrinoside G | ||||
| TCMBANKIN025683 | patrinoside d | C70H114O36 | CC1C(C(C(C(O1)OC2COC(C(C2O)O)OC3CCC4(C(C3(C)C)CCC5(C4CC=C6C5(CCC7(C6(CC(CC7)(C)C)O)C(=O)OC8C(C(C(C(O8)CO)OC9C(C(C(O9)C(CO)O)O)OC1C(C(C(C(O1)CO)O)O)O)O)O)C)C)C)OC1C(C(C(CO1)O)OC1C(C(C(C(O1)CO)O)O)O)O)O)O | ||
| TCMBANKIN026410 | giganteaside D | ||||
| TCMBANKIN026787 | 3-O-β-D-glucopyranosy 1-(1→3)-α-L-rhamanopyranosyl-(1→2)-β-D-xylopyranosyl oleanolic acid | ||||
| TCMBANKIN027046 | patrinene | C15H24 | CC1=CCC2C1CC3CCC2(C3(C)C)C | ||
| TCMBANKIN028775 | 3-o-[α-l-rhamnopyranosyl(1→2)]-[β-d-gluco-pyranosyl(1→3)]-α-l-arabinopyranosylursolicacid | C47H76O16 | |||
| TCMBANKIN029334 | 3-O-β-D-xylopyranosyl oleanolic acid 28-O-β-D-glucopyranosyl ester | ||||
| TCMBANKIN030432 | 3-O-β-D-xylopyanosyl-(1→3)-α-L-rahmnopyanosyl-(1→2)-α-L-arabinopyanosyl oleanolic acid 28-O-β-D-glucopyranosyl ester | ||||
| TCMBANKIN030606 | Scabroside K | C20H28O4 | CC(CO)C1=C2C3CC=C(CC(=O)C3(CCC2(CC1)CO)C)C=O | ||
| TCMBANKIN030791 | sulfopatrinoside i | CC1CCC2(CCC3(C(=CCC4C3(CCC5C4(CCC(C5(C)COS(=O)(=O)[O-])O)C)C)C2C1C)C)C(=O)OC6C(C(C(C(O6)COC7C(C(C(C(O7)CO)O)O)O)O)O)O.[Na+] | |||
| TCMBANKIN031083 | interoside | ||||
| TCMBANKIN031231 | 2α,3β,23-trihydroxyolean-12-en-28-oicacid o-β-d-xylopyranosyl-(1→3)-o-α-l-rhamnopy-ranosyl-(1→4)-o-β-d-glucopyranosyl-(1→6)-β-d-glucopyranosyl ester | C33H39F2N3O5 | CCOC(=O)C1CC1C2=CC(=C(C=C2)OC)C3=C(N=C(C=C3)N4CCC4)CN5C(C(OC5O)C(=C)C=C(C=C(C)F)F)C | ||
| TCMBANKIN031511 | 3,11-dioxoolean-12-en-28-oic acid | C30H44O5 | CC1(CCC2(CCC3(C(=CC(=O)C4C3(CCC5C4(CCC(=O)C5(C)C)C)C)C2C1)CO)C(=O)O)C | ||
| TCMBANKIN032038 | patrinoside c1 | C47H76O16 | CC1C(C(C(C(O1)OC2CCC3(C(C2(C)C)CCC4(C3CC=C5C4(CCC6(C5CC(CC6)(C)C)C(=O)O)C)C)C)O)OC7C(C(C(O7)C(CO)O)O)OC8C(C(C(CO8)O)O)O)O | ||
| TCMBANKIN032643 | patrinoside c | C65H106O31 | CC1C(C(C(C(O1)OC2CCC3(C(C2(C)C)CCC4(C3CC=C5C4(CCC6(C5CC(CC6)(C)C)C(=O)OC7C(C(C(C(O7)CO)OC8C(C(C(O8)C(CO)O)O)OC9C(C(C(C(O9)CO)O)O)O)O)O)C)C)C)O)OC1C(C(C(O1)C(CO)O)O)OC1C(C(C(CO1)O)O)O)O | ||
| TCMBANKIN032679 | Isopatriscabroside I | C16H26O9 | 362.37 g/mol | CC1C2CC(C(C2COC1=O)(C)O)OC3C(C(C(C(O3)CO)O)O)O | |
| TCMBANKIN033057 | scabioside d | CC1(CCC2(CCC3(C(=CCC4C3(CCC5C4(CCC(C5(C)C)OC6C(C(C(CO6)OC7C(C(C(C(O7)CO)O)O)O)O)O)C)C)C2C1)C)C(=O)OC8C(C(C(CO8)O)O)O)C | |||
| TCMBANKIN033635 | sulfapatrinoside Ⅰ | ||||
| TCMBANKIN034782 | 3-o-α-l-glucopyranosyl-(1→3)-α-l-rhamnopy-ranosyl-(1→2)-α-l-arabinopyranosyloleanclicacid | C47H76O16 | |||
| TCMBANKIN034952 | oleanolic acid 3-α-L-rhamnopyanosyl-(1→2)-β-D-xylopyranoside | ||||
| TCMBANKIN035079 | (3β, 12β)-20(30)-taraxastene-3,12-diol | C30H50O2 | CC1C2C3C(CC4C5(CCC(C(C5CCC4(C3(CCC2(CCC1=C)C)C)C)(C)C)O)C)O | ||
| TCMBANKIN035386 | campesteryl-d-glucoside-6'-palmitate | C50H88O7 | CCCCCCCCCCCCCCCC(=O)OCC1C(C(C(C(O1)OC2CCC3(C4CCC5(C(C4CC=C3C2)CCC5C(C)CCC(C)C(C)C)C)C)O)O)O | ||
| TCMBANKIN035440 | dauricine | AKOS015965146; AC-20217; SCHEMBL677474; 524-17-4 | C38H44N2O6 | 624.77 | CN1CCC2=CC(=C(C=C2C1CC3=CC=C(C=C3)OC4=C(C=CC(=C4)CC5C6=CC(=C(C=C6CCN5C)OC)OC)O)OC)OC |
| TCMBANKIN035783 | Jatamanin J | C10H18O4 | 202.25 g/mol | CC1(C(CC(C1CO)C(=C)CO)O)O | |
| TCMBANKIN035816 | 3-O-β-D-glucopyranosyl(1→3)-α-L-rhamnopyranosyl(1→2)-A-L-arabinopyranosyl oleanolic acid-28-O-β-D-glucopyranosyl(1→6)-β-D-glucopyranoside | ||||
| TCMBANKIN036586 | patrinoside K | ||||
| TCMBANKIN037090 | α-Hederin | alpha-hederin ; alpha-hederin | 751 g/mol | ||
| TCMBANKIN037277 | Oleanolic acid | Olean-12-en-28-oic acid, 3.beta.-hydroxy-; s2334; Caryophyllin; AIDS014809; Giganteumgenin C; SMR000445561; oleanolicacid; (3-beta)-3-Hydroxyolean-12-en-28-oic acid; AIDS-014809; Olean-12-en-28-oic acid, 3-hydroxy-, (3-beta)-; EINECS 208-081-6; NSC 114945; OLEANOLIC ACID; Olean-12-en-28-oic acid, 3-hydroxy-, (3beta)-; CCRIS 6493; AS-11663; SCHEMBL1699365; Virgaureagenin B; CHEBI:37659; MLS000697656; (4aS,5S,6aS,6bR,8R,8aR,10S,12aR,12bR,14bS)-10-Hydroxy-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,6a,6b,7,8,8a,9,10,11,12,12a,12b,13,14b-octadecahydro-2H-picene-4a-carboxylic acid; AKOS022168208; O5504_SIGMA; MolPort-016-633-333; Oleanolic Acid; Olean-12-en-28-oic acid, 3-beta-hydroxy- (8CI); Oleanic acid; 3beta-Hydroxyolean-12-en-28-oic acid; 3-beta-Hydroxyolean-12-en-28-oic acid; ST057162; Olean-12-en-28-oic acid, 3beta-hydroxy- (8CI); NSC114945; Oleanolic Acid (Caryophyllin); Astrantiagenin C; Olean-12-en-28-oic acid, 3-hydroxy-, (3.beta.)-; 508-02-1; (4R,6aS,6bR,8aR,10S,12aR,12bR,14bR)-10-hydroxy-2,2,6a,6b,9,9,12a-heptamethyl-3,4,4a,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydro-1H-picene-4-carboxylic acid; (4aS,6aR,6aS,6bR,8aR,10S,12aR,14bS)-10-hydroxy-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylic acid; oleanolic acid | C30H48O3 | 457 | C1([H])([H])C([H])([H])[C@](C([H])([H])[H])([C@@]([H])(C([H])([H])C([H])=C([C@@]([H])(C([H])([H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])C2([H])[H])[C@@]2(C(=O)O[H])C([H])([H])C3([H])[H])[C@@]34C( [H])([H])[H])[C@@]4(C([H])([H])[H])C([H])([H])C5([H])[H])[C@@]5([H])C(C([H])([H])[H])(C([H])([H])[H])[C@@]1([H])O[H] |
| TCMBANKIN039604 | Scabioside C | C41H66O13 | 767 g/mol | C1([H])([H])C([H])([H])[C@](C([H])([H])[H])([C@@]([H])(C([H])([H])C([H])=C([C@@]([H])(C([H])([H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])C2([H])[H])[C@@]2(C(=O)O[H])C([H])([H])C3([H])[H])[C@@]34C( [H])([H])[H])[C@@]4(C([H])([H])[H])C([H])([H])C5([H])[H])[C@@]5([H])[C@](C([H])([H])O[H])(C([H])([H])[H])[C@@]1([H])O[C@]([H])(OC([H])([H])[C@]([H])(O[C@]([H])(O[C@]([H])(C([H])([H])O[H])[C@@]6([H])O[ H])[C@]([H])(O[H])[C@@]6([H])O[H])[C@]7([H])O[H])[C@]7([H])O[H] | |
| TCMBANKIN040053 | 3-o-beta-d-glucopyranosyl-(1-3)-alpha-l-rhamnopyranosyl-(1-2)-alpha-l-arabino-pyranosyl-hederagenin-28-o-beta-d-glucopyranosyl-(1-6)-beta-d-glucopyranosyl ester | C65H106O32 | |||
| TCMBANKIN040239 | Eleutheroside K | 734.96 | |||
| TCMBANKIN041310 | 3-O-[beta-D-Glucopyranosyl-(1-4)][alpha-L-rhamnopyranosyl-(1-3)-alpha-L-rhamnopyranosyl-(1-2)-alpha-arabinopyranosyl-headeragenin | C59H96O26 | C1([H])([H])C([H])([H])[C@@](C([H])([H])[H])([C@@]([H])(C([H])([H])C([H])=C([C@@]([H])(C([H])([H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])C2([H])[H])[C@@]2(C(O[H])=O)C([H])([H])C3([H])[H])[C@@]34C ([H])([H])[H])[C@@]4(C([H])([H])[H])C([H])([H])C5([H])[H])[C@]5([H])[C@@](C([H])([H])O[H])(C([H])([H])[H])[C@@]1([H])O[C@@]6([H])[C@]([H])(O[C@@]7([H])[C@]([H])(O[H])[C@]([H])(O[C@@]([H])([C@]([H])(O[ H])[C@@]([H])(O[C@]8([H])[C@]([H])(O[H])[C@]([H])(O[H])[C@@]([H])(O[H])[C@]([H])(C([H])([H])[H])O8)[C@]([H])(O[C@@]9([H])[C@]([H])(O[H])[C@@]([H])(O[H])[C@]([H])(O[H])[C@@]([H])(C([H])([H])O[H])O9)[C@ @]%10([H])C([H])([H])O[H])O%10)[C@@]([H])(O[H])[C@]([H])(C([H])([H])[H])O7)[C@@]([H])(O[H])[C@@]([H])(O[H])C([H])([H])O6 | ||
| TCMBANKIN042628 | loganin | SDCCGMLS-0066747.P001; KBio2_001983; Spectrum_001503; BSPBio_003350; methyl (1S,4aS,6S,7R,7aS)-6-hydroxy-7-methyl-1-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-1,4a,5,6,7,7a-hexahydrocyclopenta[d]pyran-4-carboxylate; KBio2_004551; KBio1_001603; Loganin; C01433; KBioSS_001983; KBio2_007119; Spectrum2_001637; KBio3_002852; methyl (1S,4aS,6S,7R,7aS)-1-(beta-D-glucopyranosyloxy)-6-hydroxy-7-methyl-1,4a,5,6,7,7a-hexahydrocyclopenta[c]pyran-4-carboxylate; SPBio_001733; Spectrum4_001914; (1S,4aS,6S,7R,7aS)-6-hydroxy-7-methyl-1-[[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)-2-tetrahydropyranyl]oxy]-1,4a,5,6,7,7a-hexahydrocyclopenta[d]pyran-4-carboxylic acid methyl ester; Methyl (1S-(1alpha,4aalpha,6alpha,7alpha,7aalpha))-1-(beta-D-glucopyranosyloxy)-1,4a,5,6,7,7a-hexahydro-6-hydroxy-7-methylcyclopenta(c)pyran-4-carboxylate; DivK1c_006659; Spectrum5_000628; CHEBI:15771; SpecPlus_000563; (1S,4aS,6S,7R,7aS)-6-hydroxy-7-methyl-1-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-methylol-tetrahydropyran-2-yl]oxy-1,4a,5,6,7,7a-hexahydrocyclopenta[d]pyran-4-carboxylic acid methyl ester; methyl (1S,4aS,6S,7R,7aS)-6-hydroxy-7-methyl-1-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-1,4a,5,6,7,7a-hexahydrocyclopenta[d]pyran-4-carboxylate; 18524-94-2; EINECS 242-398-0; MEGxp0_000723; SPECTRUM1504066; ACon1_001749; Spectrum3_001875; ZINC03978792; 1-(beta-D-glucopyranosyloxy)-1,4a,5,6,7,7a-hexahydro-6-hydroxy-7-methylcyclopenta[c]pyran-4-carboxylic acid methyl ester; KBioGR_002535; LMPR01020102 | C18H28O10 | 404 | [C@]12([H])[C@@]([H])([C@@]([H])(C([H])([H])[H])[C@@]([H])(O[H])C1([H])[H])[C@]([H])(O[C@]([H])(O[C@@]3(C([H])([H])O[H])C([H])([H])[H])[C@]([H])(O[H])[C@]([H])(O[H])[C@@]3([H])O[H])OC([H])=C2C(OC([H]) ([H])[H])=O |
| TCMBANKIN044250 | Patrinoside | [6-hydroxy-7-(hydroxymethyl)-4-[[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]-1,4a,5,6,7,7a-hexahydrocyclopenta[c]pyran-1-yl] 3-methylbutanoate; AC1NBARN | 462.49 | ||
| TCMBANKIN045530 | hederasaponin c | C59H105O26- | CC(CC(CC(CC(CC(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(CC(COC1CCC2(C(C1(C)CO)CCC3(C2CC=C4C3(CCC5(C4CC(CC5)(C)C)C(=O)O)C)C)C)O)O)[O-])O)O)O)O)O)O)O)O)O)O)O)O)O)O)O)O)O)O)O | ||
| TCMBANKIN045638 | beta-Sitosterol-3-O-beta-D-xylopyranoside | AC1O3E0X; beta-sitosterol-3-o-beta-d-xylopyranoside; (2S,3R,4S,5R)-2-[[(3S,8S,9S,10R,13R,14S,17R)-17-[(2R)-5-ethyl-6-methylheptan-2-yl]-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]oxane-3,4,5-triol; β-sitosterol-3-o-β-d-xylopyranoside; beta-Sitosterol-3-O-beta-D-xylopyranoside_qt | 546.92 | ||
| TCMBANKIN048644 | Sulfopatrinoside II | ||||
| TCMBANKIN050106 | patrinoside d1 | C52H84O20 | CC1C(C(C(C(O1)OC2COC(C(C2O)O)OC3CCC4(C(C3(C)C)CCC5(C4CC=C6C5(CCC7(C6CC(CC7)(C)C)C(=O)O)C)C)C)OC8C(C(C(CO8)O)OC9C(C(C(C(O9)CO)O)O)O)O)O)O | ||
| TCMBANKIN057324 | Sulfur dioxide;sulfur dioxide | Sulfurous acid anhydride; Sulfur superoxide; FEMA 3039; FEMA No. 3039; Sulfur dioxide [NF]; Sulfur dioxide (SO2); 8014-94-6; CHEMBL1235997; CTK2H7729; Sulfur dioxide (NF); Caswell No. 813; [SO2]; D05961; Sulfur dioxide,liquid; Schwefeldioxyd; Schwefeldioxid; Sulfur dioxide [UN1079] [Poison gas]; Fermenicide liquid; SO2; 115004-27-8; sulphur dioxide; Sulfurous oxide; CHEBI:18422; Sulfur dioxide (SO2) 10% by volume or more SO2; AKOS015904447; SC-81833; 12396-99-5; Sulfurous anhydride; Sulfur dioxide, >=99.9%; R-764; Oxosulfane oxide #; I14-17276; HSDB 228; Fermenticide liquid; Surfur dioxide (anhydrous); sulfer dioxide; RAHZWNYVWXNFOC-UHFFFAOYSA-; Sulfur dioxide, puriss., >=99.9%; Oxosulfane oxide; EPA Pesticide Chemical Code 077601; E220; ACMC-1BHHQ; Sulfur oxide (SO2); DTXSID6029672; LS-3224; Siarki dwutlenek; Sulfur dioxide [UN1079] [Poison gas]; Fermenicide powder; Schwefeldioxyd [German]; 7446/9/5; C09306; CCRIS 9001; Sulfur(IV) oxide; dioxidosulfur; Sulfur dioxide, >=99.98%; 1239882-82-6; AC1L1ARN; TR-024070; UN1079; Siarki dwutlenek [Polish]; InChI=1/O2S/c1-3-2; SULFUR-DIOXIDE; Dioxide, Sulfur; Schwefel(IV)-oxid; UN 1079; 0UZA3422Q4; RAHZWNYVWXNFOC-UHFFFAOYSA-N; EC 231-195-2; 83008-56-4; EINECS 231-195-2; Sulfurdioxide; 89125-89-3; UNII-0UZA3422Q4; Anhydride, Sulfurous | O2S;SO2 | 64.0638 | O=S=O |
| TCMBANKIN058017 | 3-Epizaluzanin C | CHEBI:81375; AC1LAM4X; (3aS,6aR,8R,9aR,9bS)-8-hydroxy-3,6,9-trimethylidene-3a,4,5,6a,7,8,9a,9b-octahydroazuleno[5,4-d]furan-2-one; CHEMBL461700; AIDS070709; 67667-64-5; AIDS-070709; (3aS,6aR,8R,9aR,9bS)-8-hydroxy-3,6,9-trimethylidene-3a,4,5,6a,7,8,9a,9b-octahydroazuleno[4,5-b]furan-2-one; Isozaluzanin C; (3as,6ar,8r,9ar,9bs)-8-hydroxy-3,6,9-trimethylene-3a,4,5,6a,7,8,9a,9b-octahydroazuleno[5,4-d]furan-2-one; SCHEMBL17214374; (3aS,6aR,8R,9aR,9bS)-8-hydroxy-3,6,9-trimethylene-3a,4,5,6a,7,8,9a,9b-octahydroazuleno[5,4-d]furan-2-one; C17912; CTK7F2785; (3aS,6aR,8R,9aR,9bS)-8-hydroxy-3,6,9-trimethylene-3a,4,5,6a,7,8,9a,9b-octahydroazuleno[4,5-b]furan-2-one; 3-epizaluzanin c; Dehydrocostus lactone der.;zaluzain c;zaluzanin c;isozaluzanine | C15H18O3 | 246.3 g/mol | C=C1CCC2C(C3C1CC(C3=C)O)OC(=O)C2=C |
| TCMBANKIN058114 | trans-caffeic acid | 3-(3,4-dihydroxy-phenyl)-acrylic acid; caffeic acid; Caffeate; Lopac-C-0625; 71693-97-5; DivK1c_006624; KBio2_007302; (Z)-3-(3,4-dihydroxyphenyl)prop-2-enoic acid; NCGC00015206-02; CAS-3331-39-5; 60020_FLUKA; AI3-63211; 3-(3,4-Dihydroxyphenyl)-2-propenoic acid polymer; (E)-3-(3,4-dihydroxyphenyl)prop-2-enoic acid; NSC623438; 4-(2'-Carboxyvinyl)-1,2-dihydroxybenzene; KBio2_004734; (2Z)-3-(3,4-dihydroxyphenyl)prop-2-enoic acid; CHEMBL1320034; AIDS-002287; AIDS002287; 501-16-6; CHEBI:36281; Prestwick1_000902; KBio1_001568; 3-(3,4-Dihydroxyphenyl)-2-propenoic acid; AKOS000273846; OR1165; SMR000058214; Spectrum2_001612; 3,4-dihydroxycinnamate; (Z)-3-(3,4-dihydroxyphenyl)acrylic acid; Caffeicacid; KOP; AC1NO658; CCRIS 847; Caffeic acid dehydrogenation homopolymer; SPECTRUM1503987; Spectrum4_001694; SCHEMBL3682144; NCGC00017364-01; NCGC00022654-08; 4-(2-Carboxyethenyl)-1,2-dihydroxybenzene; 78734C5A-1281-44D4-B8A0-A3188AD437E3; cis-Caffeic acid; 3-(3,4-dihydroxyphenyl)acrylic acid; Cinnamic acid, 3,4-dihydroxy-; KBioGR_001988; 3,4-Dihydroxybenzeneacrylic acid; 3,4-dihydroxycinnamic acid; trans-caffeic acid; AIDS-026339; NCGC00015206-01; HSDB 7088; ZINC4482687; (2E)-3-(3,4-dihydroxyphenyl)prop-2-enoic acid; 3-(3,4-dihydroxyphenyl)prop-2-enoate; Isocaffeic acid; SBB006475; InChI=1/C9H8O4/c10-7-3-1-6(5-8(7)11)2-4-9(12)13/h1-5,10-11H,(H,12,13)/b4-2; NCGC00017364-02; EU-0100208; C01197; MolPort-001-759-162; KBioSS_002166; Caffeic acid pure; caffeic acid ; trans-Caffeate; (2E)-3-(3,4-dihydroxyphenyl)acrylic acid; NSC 57197; (2E)-3-(3,4-Dihydroxyphenyl)-2-propenoic acid; Spectrum_001686; 2-Propenoic acid, 3-(3,4-dihydroxyphenyl)-, (E)-; KBio2_002166; Caffeic acid, cis-; 2-Propenoic acid, 3-(3,4-dihydroxyphenyl)-; 3,4-Dihydroxybenzeneacrylate; 3-(3,4-Dihydroxy phenyl)-2-propenoic acid; 4361-87-9; 3,4-Dihydroxy-trans-cinnamate; caffeicacid; AR-360/40806927; EINECS 206-361-2; 60018_FLUKA; Caffeic acid polymer; (E)-3-(3,4-dihydroxyphenyl)acrylic acid; NCGC00022654-04; ZX-AL002121; C0625_SIGMA; SDCCGMLS-0002982.P003; 3-(3,4-Dihydroxyphenyl)-2-propenoic acid, homopolymer; SPBio_001643; 2-Propenoic acid, 3-(3,4-dihydroxyphenyl)- (9CI); NCGC00017364-03; 3-(3,4-dihydroxyphenyl)prop-2-enoic acid; AC1LU7RL; SPBio_002943; CHEBI:16433; AIDS026339; 2-Propenoic acid, 3-(3,4-dihydroxyphenyl)-, homopolymer; CHEBI:17395; TNP00311; SpecPlus_000528; Prestwick0_000902; MLS000069738; 3,4-dihydroxy-cinnamic acid; 3-(3,4-Dihydroxyphenyl)propenoic acid; NCI60_004400; NSC57197; Caffeic; Lopac-C-0625; NCGC00015206-01; Caffeic acid; cis-Caffeic acid; NCGC00017364-01; (Z)-3-(3,4-dihydroxyphenyl)prop-2-enoic acid; C01481; 331-39-5; NCGC00015206-02; CAS-3331-39-5; 3,4-Dihydroxycinnamic acid; CHEBI:17395; (2Z)-3-(3,4-dihydroxyphenyl)prop-2-enoic acid; TNP00311; (Z)-3-(3,4-dihydroxyphenyl)acrylic acid; Caffeate; 1- coffee acid | C9H8O4 | 180.16 g/mol | C1=CC(=C(C=C1C=CC(=O)O)O)O |
| TCMBANKIN058568 | paulownin; (+)-paulownin; isopaulownin; (-)-paulownin | Epipaulownin; (1R,3aR,4S,6aS)-1,4-bis(1,3-benzodioxol-5-yl)-3,3a,4,6-tetrahydro-1H-furo[3,4-c]furan-6a-ol; 13040-46-5; ACon1_001000; 1H,3H-Furo(3,4-c)furan-3a(4H)-ol, 1,4-bis(1,3-benzodioxol-5-yl)dihydro-, (1alpha,3aalpha,4alpha,6aalpha)-; ZINC05037439; MEGxp0_001306 | C20H18O7 | 370.35 | C1C2C(OCC2(C(O1)C3=CC4=C(C=C3)OCO4)O)C5=CC6=C(C=C5)OCO6 |
| TCMBANKIN059152 | campesterol-D-goycoside | 24-methylcholest-5-enyl-3belta-o-glucopyranoside | C34H58O6 | 562.92 | CC(C)C(C)CCC(C)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)OC5C(C(C(C(O5)CO)O)O)O)C)C |
| TCMBANKIN059626 | 3-o-β-d-xylopyranosyloleanolicacid | C35H56O7 | CC1(CCC2(CCC3(C(=CCC4C3(CCC5C4(CCC(C5(C)C)OC6C(C(C(CO6)O)O)O)C)C)C2C1)C)C(=O)O)C | ||
| TCMBANKIN059631 | Cauloside A | C35H56O8 | 604.8 g/mol | CC1(CCC2(CCC3(C(=CCC4C3(CCC5C4(CCC(C5(C)CO)OC6C(C(C(CO6)O)O)O)C)C)C2C1)C)C(=O)O)C | |
| TCMBANKIN059634 | scabioside c | C41H66O13 | 767 g/mol | CC1(CCC2(CCC3(C(=CCC4C3(CCC5C4(CCC(C5(C)CO)OC6C(C(C(CO6)OC7C(C(C(C(O7)CO)O)O)O)O)O)C)C)C2C1)C)C(=O)O)C | |
| TCMBANKIN060216 | leonoside b | C36H48O19 | 784.8 g/mol | CC1C(C(C(C(O1)OC2C(C(OC(C2OC(=O)C=CC3=CC(=C(C=C3)O)OC)CO)OCCC4=CC(=C(C=C4)OC)O)O)OC5C(C(C(CO5)O)O)O)O)O | |
| TCMBANKIN060229 | Glycoside H1;kalopanaxsaponin B;akebin b;akebin f;Akeboside sth;tauroside h 2 | C59H96O26 | 1149.48 | CC1C(C(C(C(O1)OC2C(OC(C(C2O)O)OCC3C(C(C(C(O3)OC(=O)C45CCC(CC4C6=CCC7C8(CCC(C(C8CCC7(C6(CC5)C)C)(C)CO)OC9C(C(C(CO9)O)O)OC1C(C(C(C(O1)C)O)O)O)C)(C)C)O)O)O)CO)O)O)O | |
| TCMBANKIN060535 | pentologenin 5-O-β-D-glucopyrannoside;niga-ichigoside f1;pruvuloside b;niga-ichigoside f2;nigainchigoside F1;2α,3β,19α,23-tetrahydroxyurs-l2-en-28-oic acid β-D-glucopyranosyl ester;nigachigoside f1;niga ichigoside F1 | C36H58O11 | 666.8 g/mol | CC1CCC2(CCC3(C(=CCC4C3(CCC5C4(CC(C(C5(C)CO)O)O)C)C)C2C1(C)O)C)C(=O)OC6C(C(C(C(O6)CO)O)O)O | |
| TCMBANKIN060679 | stigmasterol | C29H48O | 412.7 g/mol | CCC(C=CC(C)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)O)C)C)C(C)C | |
| TCMBANKIN060693 | Sitogluside | C35H60O6 | 576.85g/mol | CCC(CCC(C)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)OC5C(C(C(C(O5)CO)O)O)O)C)C)C(C)C | |
| TCMBANKIN061528 | scopoletin | NINDS_000720; 7-hydroxy-6-methoxy-coumarin; NCGC00016349-05; 6-methoxy-7-hydroxycoumarin; 6-methoxy-7-oxidanyl-chromen-2-one; CHEBI:17488; SPBio_002884; HMS1571A05; RODXRVNMMDRFIK-UHFFFAOYSA-N; NCGC00016349-08; TR-029034; 5-18-03-00203 (Beilstein Handbook Reference); Acid, Gelseminic; 6-Methylesculetin; UNII-KLF1HS0SXJ; 7-hydroxy 6-methoxy coumarine; Scopoletin, >=99%; AB00443525; beta -methylesculetin; CS-5791; BRN 0156296; NCGC00094973-02; SR-01000841273-4; HMS2268G04; SCHEMBL147702; scopoletin ; Prestwick3_000962; CHEMBL71851; Escopoletin; Spectrum2_001207; HMS2098A05; NCGC00016349-07; NCGC00094973-03; Murrayetin; 7-Hydroxy-6-methoxy-2H-1-benzopyran-2-one; Bio-0208; NCGC00016349-02; Prestwick2_000962; ZB002243; BG01509594; NCGC00016349-03; BPBio1_001061; Scopoletin, analytical standard; AX8035441; 0B4B9FAA-686D-4977-AA08-65F8E4F1977C; BRD-K96163925-001-06-5; ZX-AN021883; FCH1115349; AC1NQX27; 7-hydroxy-6-methoxy-chromen-2-one; KBio3_002444; DTXSID0075368; 7-Hydroxy-5-methoxycoumarin; SC-90283; ST24045669; b-Methylaesculetin; KBioGR_001348; 7-Hydroxy-6-methoxy-2H-chromen-2-one #; Gelseminic acid; ZX-AFC000681; S0367; MLS002154074; 4CN-0905; 6-O-Methylesculetin; HMS502D22; KLF1HS0SXJ; MCULE-6077230919; MLS002472878; IDI1_000720; SPECTRUM1502242; Aesculetin 6-methyl ether; C-30831; MFCD00006872; Scopoletol; Buxuletin; AB0019688; CC-34387; Chrysotropic Acid; RTR-029034; ACon1_000143; CCRIS 3592; 6-Methoxyumbelliferone; LS-55217; NSC-405647; NSC 405647; 6-Methoxy-7-hydroxycoumarin; Esculetin-6-methyl ether; BDBM50156693; ZX-AT021192; AK111291; Scopoletin, United States Pharmacopeia (USP) Reference Standard; 7-Hydroxy-6-methoxy-2H-chromen-2-one; I14-14171; Prestwick1_000962; PubChem15777; MolPort-000-707-493; DivK1c_000720; A844290; AN-42608; NCGC00016349-04; ST056287; ZINC57733; BSPBio_002944; Chrysatropic acid; NCI60_003834; CAS-92-61-5; Acid, Chrysotropic; NSC405647; SR-01000841273; Prestwick0_000962; BSPBio_000963; KBio1_000720; FT-0631451; beta-Methylesculetin; Spectrum4_001054; SR-01000841273-3; AJ-09778; 7-Hydroxy-6-methoxycoumarin; W-3522; MEGxp0_001192; HY-N0342; NCGC00016349-06; Scopoletine; 7-hydroxy-6-methoxy-1-benzopyran-2-one; 006S872; OR22352; S-2000; NCGC00094973-01; EINECS 202-171-9; TNP00096; KS-00000YGS; Spectrum5_000654; Spectrum3_001532; TD8126; 2H-1-Benzopyran-2-one, 7-hydroxy-6-methoxy- (9CI); SPBio_000994; AKOS000277133; COUMARIN, 7-HYDROXY-6-METHOXY-; 2H-1-Benzopyran-2-one, 7-hydroxy-6-methoxy-; SMR000112541; BIDD:PXR0125; CCG-39140; Esculetin 6-methyl ether; D05QOR; 92-61-5; ALBB-023369; 7-hydroxy-6-methoxychromen-2-one; C01752; BIS1402; HMS1921N16; KB-249948; .beta.-Methylesculetin; NCGC00016349-01; Baogongteng B; 7-hydroxy-6-methoxy-chromen-2-one; KBio3_002444; NINDS_000720; 7-Hydroxy-5-methoxycoumarin; 7-hydroxy-6-methoxy-coumarin; Scopoletine; S2500_SIGMA; 7-hydroxy-6-methoxy-2H-chromen-2-one; CHEBI:17488; KBioGR_001348; SPBio_002884; Prestwick1_000962; NCGC00094973-01; 5-18-03-00203 (Beilstein Handbook Reference); EINECS 202-171-9; scopoletol; TNP00096; AIDS-014975; Gelseminic acid; DivK1c_000720; 6-O-Methylesculetin; Spectrum5_000654; Spectrum3_001532; 6-Methylesculetin; 2H-1-Benzopyran-2-one, 7-hydroxy-6-methoxy- (9CI); MEGxp0_001192; SPBio_000994; Scopoletin; 84792_FLUKA; IDI1_000720; COUMARIN, 7-HYDROXY-6-METHOXY-; 2H-1-Benzopyran-2-one, 7-hydroxy-6-methoxy-; ST056287; NCGC00094973-02; BRN 0156296; SPECTRUM1502242; Esculetin 6-methyl ether; BSPBio_002944; Chrysatropic acid; NCI60_003834; CAS-92-61-5; Prestwick3_000962; 7-hydroxy-6-methoxy-2-chromenone; Escopoletin; Spectrum2_001207; NCGC00094973-03; Murrayetin; 92-61-5; NSC405647; BSPBio_000963; NCGC00016349-02; KBio1_000720; 7-hydroxy-6-methoxychromen-2-one; Prestwick0_000962; 7-Hydroxy-6-methoxy-2H-1-benzopyran-2-one; C01752; ZINC00057733; AIDS014975; Prestwick2_000962; Spectrum4_001054; beta-Methylesculetin; ACon1_000143; BPBio1_001061; CCRIS 3592; 6-Methoxyumbelliferone; 7-Hydroxy-6-methoxycoumarin; .beta.-Methylesculetin; NCGC00016349-01; NSC 405647; 6-Methoxy-7-hydroxycoumarin; Esculetin-6-methyl ether; 6-methoxy-7-hydroxycoumarin; 7- hydroxy- 6-methoxy- coumarin; 6-methoxy-7-hydroxy coumarin; Scopoletol | C10H8O4 | 192.17 g/mol | COC1=C(C=C2C(=C1)C=CC(=O)O2)O |
| TCMBANKIN061530 | scopolin | scopolin ; Scopolin; 6-METHOXY-7-{[(2S,3R,4S,5S,6R)-3,4,5-TRIHYDROXY-6-(HYDROXYMETHYL)OXAN-2-YL]OXY}-3,4-DIHYDRO-1-BENZOPYRAN-2-ONE;6-methoxy-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-2-one; 7-(beta-D-glucopyranosoyloxy)-6-methoxy-2H-1-benzopyran-2-one; 6-methoxy-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-chromen-2-one; CHEBI:16065; 6-methoxy-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-methylol-tetrahydropyran-2-yl]oxy-coumarin; ZINC04082214; STOCK1N-54345; 6-methoxy-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-chromen-2-one; 6-methoxy-7-[[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)-2-tetrahydropyranyl]oxy]-2-chromenone;6-methoxy-2-oxo-2H-chromen-7-yl beta-D-glucopyranoside | C16H18O9 | 354.31 g/mol | COC1=C(C=C2C(=C1)C=CC(=O)O2)OC3C(C(C(C(O3)CO)O)O)O |
| TCMBANKIN061662 | Patuletin | 519-96-0; 2-(3,4-Dihydroxyphenyl)-3,5,7-trihydroxy-6-methoxy-4-benzopyrone; 2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-6-methoxy-4-chromenone; patuletin; patuletin ; 2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-6-methoxy-chromen-4-one; Quercetagetin 6-methyl ether; 2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-6-methoxychromen-4-one; EINECS 208-280-8; C10118; 2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-6-methoxy-chromone; 6-methoxyquercetin | C16H12O8 | 332.26 g/mol | COC1=C(C2=C(C=C1O)OC(=C(C2=O)O)C3=CC(=C(C=C3)O)O)O |
植物对应的疾病
| 疾病ID | 病名 | 疾病类型 | MeSH | 参考文献 |
|---|
植物对应的靶点
| 靶点ID | 基因名 | 基因别名 | 描述 | 染色体位置 | Map_Location | 基因类型 |
|---|
滇ICP备16009434号-1 |
Dai SX Lab